| |
| |
|
| Insider
Information: |
Lawrence David |
| Relationship: |
Chief, Bus. Ops & PAO |
| City: |
Hawthorne |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
13,811 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,933 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,811 |
|
|
| Total
Value |
$6,933 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief, Bus. Ops & PAO |
2020-12-01 |
13,811 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Chief Financial OfficerOfficer |
• – – |
2006-02-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,230 |
|
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-11-06 |
4 |
AS |
$15.97 |
$238,434 |
D/D |
(14,853) |
49,377 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-11-20 |
4 |
AS |
$17.76 |
$19,180 |
D/D |
(1,058) |
44,319 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-11-20 |
4 |
AS |
$18.97 |
$77,087 |
D/D |
(4,000) |
45,377 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-12-11 |
4 |
AS |
$16.91 |
$23,192 |
D/D |
(1,365) |
42,954 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-12-20 |
4 |
AS |
$15.70 |
$94,019 |
D/D |
(5,941) |
37,013 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-01-23 |
4 |
AS |
$17.37 |
$104,262 |
D/D |
(5,941) |
31,072 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-02-23 |
4 |
AS |
$23.00 |
$139,433 |
D/D |
(5,941) |
25,131 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-03-09 |
4 |
AS |
$19.51 |
$26,895 |
D/D |
(1,365) |
23,766 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-03-22 |
4 |
AS |
$19.55 |
$116,622 |
D/D |
(5,941) |
19,190 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-03-22 |
4/A |
S |
$19.55 |
$116,622 |
D/D |
(5,941) |
17,825 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-04-23 |
4 |
AS |
$23.65 |
$21,197 |
D/D |
(883) |
18,307 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-05-23 |
4 |
AS |
$24.11 |
$21,347 |
D/D |
(883) |
17,424 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-06-15 |
4 |
S |
$18.48 |
$37,087 |
D/D |
(2,007) |
14,052 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-09-12 |
4 |
AS |
$15.91 |
$32,087 |
D/D |
(2,007) |
12,045 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-09-26 |
4 |
AS |
$18.56 |
$37,703 |
D/D |
(2,008) |
10,037 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-10-23 |
4 |
AS |
$19.95 |
$20,210 |
D/D |
(1,004) |
9,033 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-11-21 |
4 |
AS |
$17.00 |
$17,201 |
D/D |
(1,003) |
8,030 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-12-10 |
4 |
AS |
$20.22 |
$36,718 |
D/D |
(1,800) |
6,230 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-12-21 |
4 |
AS |
$20.50 |
$22,736 |
D/D |
(1,107) |
5,123 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-12-27 |
4 |
AS |
$23.00 |
$161,381 |
D/D |
(7,000) |
5,123 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-12-27 |
4 |
OE |
$2.60 |
$18,200 |
D/D |
7,000 |
12,123 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-01-11 |
4 |
AS |
$25.00 |
$175,000 |
D/D |
(7,000) |
5,123 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-01-11 |
4 |
OE |
$2.60 |
$18,200 |
D/D |
7,000 |
12,123 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-01-23 |
4 |
AS |
$22.31 |
$25,233 |
D/D |
(1,107) |
4,016 |
0 |
- |
|
92 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
